Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shriya Deshmukh

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Targeted Oncology|November 15, 2024
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for ChondrosarcomaShriya Deshmukh, Ciara Kelly, Gabriel Tinoco
The FEBS Journal|May 10, 2021
Oncohistones: a roadmap to stalled developmentShriya Deshmukh, Adam Ptack, Brian Krug, et al.
Trends in Cell Biology|June 7, 2021
Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumoursBrian Krug, Ashot S Harutyunyan, Shriya Deshmukh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2019
The neurologist's role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectivesJean-Pierre R Falet, Shriya Deshmukh, Abrar Al-Jassim, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progressionSiddhant U Jain, Sima Khazaei, Dylan M Marchione, et al.
Nature Communications|May 16, 2019
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanismSiddhant U Jain, Truman J Do, Peder J Lund, et al.
Molecular Cell|October 13, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, et al.
Human Molecular Genetics|May 31, 2022
Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4)Malvin Jefri, Xin Zhang, Patrick S Stumpf, et al.
Investigative Ophthalmology & Visual Science|September 4, 2020
Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant ExonizationMatteo Di Scipio, Erika Tavares, Shriya Deshmukh, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Targeted Oncology|November 15, 2024
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for ChondrosarcomaShriya Deshmukh, Ciara Kelly, Gabriel Tinoco
The FEBS Journal|May 10, 2021
Oncohistones: a roadmap to stalled developmentShriya Deshmukh, Adam Ptack, Brian Krug, et al.
Trends in Cell Biology|June 7, 2021
Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumoursBrian Krug, Ashot S Harutyunyan, Shriya Deshmukh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2019
The neurologist's role in disabling multiple sclerosis: A qualitative study of patient and care provider perspectivesJean-Pierre R Falet, Shriya Deshmukh, Abrar Al-Jassim, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progressionSiddhant U Jain, Sima Khazaei, Dylan M Marchione, et al.
Nature Communications|May 16, 2019
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanismSiddhant U Jain, Truman J Do, Peder J Lund, et al.
Molecular Cell|October 13, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, et al.
Human Molecular Genetics|May 31, 2022
Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4)Malvin Jefri, Xin Zhang, Patrick S Stumpf, et al.
Investigative Ophthalmology & Visual Science|September 4, 2020
Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant ExonizationMatteo Di Scipio, Erika Tavares, Shriya Deshmukh, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Pageof 2